NATCOPHARM.NS · Natco Pharma Limited
India · RS rating 23 · As of 2026-10-14
| Price | 782.65 INR |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 23 / 48 / 14 / 61 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 14 / 18 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | -22.9% |
| Sales growth Q/Q | -0.5% |
| Distance from 52-week high | +35.1% |
| Market cap (USD) | $1.5B |